Prosight Management as of June 30, 2021
Portfolio Holdings for Prosight Management
Prosight Management holds 46 positions in its portfolio as reported in the June 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Prothena Corp SHS (PRTA) | 13.6 | $22M | 422k | 51.41 | |
Albireo Pharma | 6.5 | $10M | 295k | 35.18 | |
Arena Pharmaceuticals Com New | 5.8 | $9.3M | 137k | 68.20 | |
Haemonetics Corporation (HAE) | 5.6 | $8.9M | 134k | 66.64 | |
Cue Biopharma (CUE) | 4.6 | $7.3M | 630k | 11.65 | |
Encompass Health Corp (EHC) | 4.3 | $6.9M | 88k | 78.03 | |
Aldeyra Therapeutics (ALDX) | 4.2 | $6.7M | 595k | 11.33 | |
Kezar Life Sciences (KZR) | 3.5 | $5.6M | 1.0M | 5.43 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 3.4 | $5.5M | 27k | 201.62 | |
Exicure | 3.4 | $5.4M | 3.6M | 1.50 | |
Zogenix Com New | 3.3 | $5.3M | 306k | 17.28 | |
Zimmer Holdings (ZBH) | 3.2 | $5.1M | 32k | 160.83 | |
Galapagos Nv Spon Adr (GLPG) | 3.1 | $5.0M | 72k | 68.89 | |
Convey Hldg Parent | 2.9 | $4.7M | 410k | 11.38 | |
Kalvista Pharmaceuticals (KALV) | 2.7 | $4.3M | 181k | 23.96 | |
Meiragtx Holdings (MGTX) | 2.7 | $4.2M | 274k | 15.50 | |
R1 Rcm | 2.4 | $3.8M | 172k | 22.24 | |
Morphic Hldg (MORF) | 2.3 | $3.7M | 64k | 57.39 | |
Iovance Biotherapeutics (IOVA) | 2.3 | $3.6M | 139k | 26.02 | |
Metacrine Ord | 2.1 | $3.3M | 869k | 3.80 | |
Proqr Thrapeutics N V Shs Euro (PRQR) | 1.8 | $2.8M | 420k | 6.74 | |
Quantum Si Com Cl A (QSI) | 1.7 | $2.8M | 227k | 12.26 | |
UnitedHealth (UNH) | 1.3 | $2.0M | 5.0k | 400.40 | |
LHC | 1.2 | $2.0M | 9.9k | 200.24 | |
Aurinia Pharmaceuticals (AUPH) | 1.1 | $1.7M | 130k | 12.96 | |
Ati Physical Therapy Com Cl A | 1.0 | $1.7M | 173k | 9.54 | |
Medtronic SHS (MDT) | 0.9 | $1.4M | 11k | 124.09 | |
Irhythm Technologies (IRTC) | 0.8 | $1.3M | 20k | 66.34 | |
Cellectis S A Spon Ads (CLLS) | 0.8 | $1.3M | 86k | 15.47 | |
Oscar Health Cl A (OSCR) | 0.7 | $1.2M | 55k | 21.49 | |
Albireo Pharma Call Call Option | 0.7 | $1.2M | 33k | 35.17 | |
Evolent Health Cl A (EVH) | 0.7 | $1.1M | 52k | 21.13 | |
Clover Health Investments Com Cl A (CLOV) | 0.7 | $1.1M | 79k | 13.32 | |
Akumin | 0.6 | $1.0M | 328k | 3.15 | |
Aurinia Pharmaceuticals Call Call Option | 0.5 | $871k | 67k | 12.96 | |
Nuvation Bio Com Cl A (NUVB) | 0.5 | $854k | 92k | 9.31 | |
Sio Gene Therapies Common | 0.4 | $699k | 256k | 2.73 | |
Oncorus | 0.4 | $690k | 50k | 13.80 | |
Option Care Health Com New (OPCH) | 0.4 | $610k | 28k | 21.88 | |
Assembly Biosciences | 0.4 | $578k | 149k | 3.88 | |
X4 Pharmaceuticals (XFOR) | 0.4 | $571k | 88k | 6.50 | |
Reneo Pharmaceuticals (RPHM) | 0.3 | $513k | 55k | 9.34 | |
Aptose Biosciences Com New | 0.3 | $442k | 133k | 3.32 | |
Organogenesis Hldgs (ORGO) | 0.3 | $417k | 25k | 16.61 | |
Cano Health Com Cl A | 0.2 | $281k | 23k | 12.11 | |
Adma Biologics (ADMA) | 0.1 | $184k | 115k | 1.60 |